A deeptech startup, Leumas, has raised $2.2 million in seed funding to expand its modular robotic manufacturing systems for the pharmaceutical and wellness industries. The company was founded in 2016 by Subhajit Biswas and Nitesh K and is headquartered in Bengaluru. The system uses AI, robotics, and vision-based quality control to enable flexible, traceable, on-demand production. Its production lines are designed to deal with different volumes and formulations, setting them apart from traditional factories.
Working with wellness brands, the company has scaled to 120+ products across India, the US, and MENA (Middle East and North Africa). It has partnered with pharma and food research institutions to develop pilot factories. In a pre-seed funding round in 2023, Leumas raised INR 7 crores. The company targets a $100 billion opportunity in outsourced manufacturing through a factory-as-a-service model. The pharmaceutical contract manufacturing market was valued at $129.19 billion in 2024, and the expectation is for it to reach $224.51 billion by 2030, according to industry reports.
What Leumas has to offer aligns with the growing demand for personalized medicine and modular scale, which traditional manufacturing models struggle with. Geopolitical changes are increasing the demand for distributed, capital-efficient manufacturing solutions. Its competitors include ASPO Pharmaceuticals LLP, Janus Biotech, and Innovexia Lifesciences.
